{"url_path":"/sec/evfm/8-k/2026-07-20/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033910-index.html","accession_number":"0001493152-26-033910","cik":"0001618835","ticker":"EVFM","issuer_name":"Evofem Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-033910-index.html","primary_entity_key":"0001618835","primary_entity_name":"Evofem Biosciences, Inc."},"word_count":174,"has_tables":true,"body_markdown":"**Item\n7.01.**\n**Regulation\nFD Disclosure.**\n\n \n\nEvofem\nBiosciences, Inc. (the “Company”) from time to time presents and/or distributes to the investment community at various industry\nand other conferences slide presentations to provide updates and summaries of its business. The Company is posting to the “Investors”\nportion of its website at www.evofem.com a copy of its current corporate slide presentation. These slides are attached to this\nCurrent Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached\nhereto as Exhibit 99.1.\n\n \n\nThe\ninformation in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for\npurposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the\nliabilities of that Section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of\n1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."}